SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-99-004650
Filing Date
1999-05-14
Accepted
1999-05-14 00:00:00
Documents
2
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 NYMOX PHARMACEUTICAL CORPORATION 20-F 157024
2 SOLE NON-EXCLUSIVE LICENSE AND SUPPLY AGREEMENT EX-10.6 59670
  Complete submission text file 0000950123-99-004650.txt   218262
Mailing Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA, H9S 1B1 A8
Business Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA H9S 1B1 A8 5146363122
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-12033 | Film No.: 99621399
SIC: 2835 In Vitro & In Vivo Diagnostic Substances